In the pursuit of brighter, more youthful-looking eyes, the under-eye area often proves to be one of the most challenging to treat. Due to its thin and delicate skin, this region is prone to early signs of ageing such as fine lines, wrinkles, dark circles, and skin laxity — often worsened by sun exposure, fatigue, and collagen loss.
This advanced Korean-developed injectable treatment combines hyaluronic acid (HA) with poly-D,L-lactic acid (PDLLA) — a hybrid formulation specifically engineered for delicate areas like the tear trough. It offers both immediate hydration and long-term collagen regeneration, making it a suitable non-surgical solution for under-eye rejuvenation.
Key components:
This next-generation hybrid injectable from Korea is particularly effective for:
By harnessing the synergistic effects of HA and PDLLA, this treatment delivers progressive and natural-looking improvements in skin quality, with results that continue to evolve over several months.
Learn more about full-face applications of this injectable collagen skinbooster here.
This next-generation Korean injectable offers a comprehensive solution for under-eye rejuvenation. By combining hyaluronic acid (HA) and poly-D,L-lactic acid (PDLLA) in one treatment, it provides both immediate skin hydration and long-term collagen stimulation—without the heaviness or swelling commonly associated with traditional dermal fillers.
Its safety profile, especially in delicate areas such as the tear trough, and ability to deliver progressive yet natural-looking results make it an ideal option for patients seeking to restore brightness and smoothness under the eyes without undergoing surgery.
Key benefits of this hybrid injectable:
Dark circles under the eyes are typically caused by a combination of volume loss, skin thinning, pigmentation, and impaired circulation. This injectable is specifically formulated to address these factors through a synergistic mechanism.
This dual-technology approach not only improves the appearance of the under-eye region but also supports healthier, more resilient skin over the long term.
Fine lines and wrinkles are some of the earliest signs of ageing to appear in the delicate under-eye region. This hybrid PDLLA + HA injectable addresses these concerns through a two-pronged approach.
This progressive rejuvenation makes the treatment ideal for patients seeking subtle, natural improvements without the risk of an overfilled or puffy appearance.
As collagen levels gradually increase due to PDLLA activation, the skin around the eyes becomes firmer, more resilient, and more youthful in appearance. Improved skin elasticity helps to reduce under-eye crepiness and sagging, while enhanced dermal density contributes to smoother texture overall.
The HA component complements this by delivering deep hydration, giving the skin a fresher, healthier glow. The result is an improvement not just in wrinkles, but in overall skin quality.
With age, the under-eye area can appear more tired or sunken due to skin thinning, collagen loss, and mild volume depletion. While traditional tear trough fillers remain the gold standard for significant volume restoration, this hybrid PDLLA + HA collagen booster can offer subtle improvement in patients with mild hollowing.
This treatment is not a replacement for tear trough fillers, but it is well-suited for patients looking to improve skin quality, mild hollowness, and early signs of fatigue — all without the risk of puffiness or overcorrection.
This collagen-stimulating eye rejuvenation procedure involves a series of targeted injections designed to improve skin quality, hydration, and elasticity in the delicate under-eye region. Dr Edwin offers two different techniques for administering this hybrid PDLLA + HA injectable, each tailored to individual patient needs, skin thickness, and treatment goals.
This method involves delivering the injectable using a blunt-tipped microcannula. It is ideal for patients seeking minimal downtime, as the cannula reduces the risk of bruising and swelling while allowing precise placement of the solution beneath the skin.
Benefits of the cannula technique:
The Dermashine Pro system uses ultra-fine needles to administer the hybrid PDLLA + HA injectable across the superficial dermis. This method is particularly well-suited for patients with crepey skin, fine lines, or those looking to improve overall skin texture and hydration in the under-eye area.
Compared to manual injections, the Dermashine Pro offers several advantages:
It is especially effective for patients who prefer a less invasive experience while achieving smoother skin and enhanced hydration.
Watch a demonstration of this treatment below
1. Consultation
A detailed consultation with Dr Edwin will be conducted to assess skin condition, degree of hollowing, and suitability for the treatment. Based on individual needs, the most appropriate technique — cannula or microinjection — will be recommended.
2. Preparation
The under-eye area will be thoroughly cleansed, and a topical anaesthetic will be applied to ensure comfort. For cannula procedures, precise entry points will be marked.
3. Injection
4. Post-Treatment Care
Some mild redness or swelling may occur, typically resolving within a few hours to a few days. Patients will receive detailed aftercare instructions to support healing and optimise results.
Treatment frequency depends on individual skin condition, degree of ageing, and desired results. Most patients benefit from an initial induction phase followed by periodic maintenance sessions to sustain long-term skin improvements.
A series of 3 to 5 treatment sessions is typically recommended, spaced approximately 3 to 4 weeks apart. This structured approach supports ongoing collagen stimulation while replenishing skin hydration in the delicate under-eye area. Over this period, patients can expect gradual improvements in fine lines, skin elasticity, and texture.
The hybrid formulation of poly-D,L-lactic acid (PDLLA) and hyaluronic acid (HA) works synergistically to enhance both short-term skin hydration and long-term dermal remodeling.
Following the initial course, maintenance treatments are usually recommended every 6 to 9 months to prolong and enhance the results. These touch-up sessions continue to support collagen renewal and help maintain overall skin quality.
Depending on individual factors such as age, lifestyle, and skin metabolism, some patients may benefit from more frequent maintenance intervals.
Results from hybrid PDLLA + HA treatments may last beyond one year in many patients. With proper aftercare and ongoing maintenance, skin around the eyes can remain smoother, firmer, and more youthful-looking over time.
Patients can expect a progressive improvement in the under-eye area as the hybrid PDLLA + HA collagen booster works in stages. Results unfold gradually and are most noticeable over a series of treatments.
Immediately after each session:
After 2 to 3 sessions:
By 2 to 3 months:
As collagen stimulation continues post-treatment, results can continue to improve for several months, especially when paired with maintenance sessions every 6 to 9 months.
This treatment is ideal for patients who experience early signs of ageing or tiredness around the eyes but do not require full-volume correction with tear trough fillers.
Suitable for:
It is especially beneficial for younger patients, or those who wish to prevent further ageing changes before more invasive interventions are required.
Under-eye treatments require precision, experience, and a deep understanding of facial anatomy. Dr Edwin Lim has extensive experience in tailoring injectable treatments based on each patient’s skin condition, ageing severity, and anatomical structure.
At Edwin Lim Medical Aesthetic Clinic, your treatment is not just about aesthetics—it’s about achieving healthy, long-term skin rejuvenation with scientifically proven methods.
The injectable used is Juvelook, a Korean formulation that combines hyaluronic acid (HA) and poly-D,L-lactic acid (PDLLA). HA provides immediate hydration and plumping, while PDLLA stimulates your skin’s natural collagen production over time. Together, they help improve elasticity, firmness, and under-eye texture.
Juvelook is not a volumising filler. While tear trough fillers are intended to restore deeper volume, Juvelook focuses on improving under-eye skin quality. It addresses fine lines, mild hollowness, and dark circles through hydration and collagen stimulation, making it suitable for patients seeking a gradual and natural enhancement.
The typical treatment plan for Juvelook includes 3 to 5 sessions spaced 3 to 4 weeks apart. Maintenance treatments are recommended every 6 to 9 months to sustain collagen production and skin improvements. Dr Edwin will personalise your plan based on your skin’s condition and goals
Downtime after Juvelook is minimal. You may experience mild redness, swelling, or tiny injection marks, which usually subside within 1 to 2 days. When using the cannula method, bruising is less common. If performed with the Dermashine Pro system, temporary pinpoint marks may be visible but resolve quickly.
Juvelook is well tolerated by most patients. A numbing cream is applied before the procedure. The Dermashine Pro method is typically more comfortable, as it uses ultra-fine needles and delivers the injectable at a controlled depth, resulting in less pain and greater consistency than manual injections.
Yes, Juvelook can be combined with other treatments such as Rejuran Eye (e.g. 婴儿针), laser therapy, or skinboosters. Depending on your concerns—whether fine lines, skin laxity, or pigmentation—Dr Edwin may recommend a combination approach for enhanced results.
Yes, Juvelook is formulated with finely calibrated PDLLA microparticles designed for safe use in thin, delicate areas like the tear trough. The risk of lumpiness or granulomas is low when administered properly, and Dr Edwin uses precise techniques to ensure both safety and efficacy.
With Juvelook, patients typically notice improved skin hydration and plumpness within the first week. Collagen stimulation begins gradually, with visible improvements in fine lines, texture, and elasticity developing over the next 6 to 12 weeks. Results continue to enhance with each session and may peak several months after the final treatment.
Juvelook is suitable for adults of various age groups who are looking to improve fine lines, mild dark circles, or crepey under-eye skin. Younger patients in their 20s and 30s may use it preventatively, while older individuals may benefit from its regenerative collagen-stimulating effects. Suitability will depend on skin thickness, degree of volume loss, and overall eye structure.
Both treatments aim to improve under-eye skin quality, but they work differently. Salmon DNA-based injectables (commonly known as 婴儿针 or Rejuran Eye) focus on cellular repair and wound healing. Juvelook, on the other hand, stimulates collagen while also hydrating the skin, offering a longer-lasting structural benefit. In some cases, both treatments may be combined for synergistic results.
